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the elderly and in women, as well as the 
risks for CVD associated with a reduced 
estimated level of renal function. ? ese 
 ndings have broad importance to the 
understanding of the epidemiology of 
CKD and its consequences and add fur-
ther to the urgency of a re-evaluation of 
the performance of eGFR. ? ey generate 
questions regarding the utility of renal 
function–estimating equations based on 
serum creatinine, such as eGFR-MDRD, 
for the assessment of renal function in 
clinical medicine. Clearly, these formulae 
and their application to epidemiology 
have helped to heighten awareness of 
CKD and its complications, but to move 
forward, new approaches are needed (i) 
that obviate the use of surrogates for cre-
atinine generation; (ii) that take account 
of the e1 ect of age and gender on GFR; 
and (iii) that use markers for GFR other 
than creatinine. Perhaps cystatin C or a 
combination of cystatin C and creatinine 
will ultimately ful ll this latter role. 22 ? e 
eGFR-MDRD and other estimates of 
renal function based on serum creatinine 
alone require an objective performance 
review of their roles in clinical medicine. 
GFR estimation must evolve into a more 
precise and accurate art. 
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 The international realities of live 
donor kidney transplantation 
 Francis L.  Delmonico 1 
 Horvat and coauthors report on trends in living kidney transplantation 
in 69 countries, having assembled the data from registries, national 
societies, the medical literature, and direct contact with transplant 
centers. Assembling worldwide data on live-donor kidney transplants is 
a commendable accomplishment that serves the international 
transplant community well. 
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 In this issue of  Kidney International , 
Horvat and coauthors 1 report on trends 
in living kidney transplantation in 69 
countries, having assembled the data 
from registries, national societies, and 
the medical literature. In those countries 
in which there were no registry data, the 
authors contacted the transplant centers 
directly to acquire the data. Assembling 
worldwide data on live-donor kidney 
transplants is a commendable accom-
plishment that serves the international 
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transplant community well. What is now 
evident in many parts of the world is the 
reliance on the live donor as the pre-
ferred source of the kidney transplant. 
An explanation for this development is 
derived from widely known reference 
data initially compiled by Cecka more 
than a decade ago. ? e allogra$  survival 
for an unrelated kidney transplant 
(determined by kidney half-life) is equal 
to the survival achieved by the transplan-
tation of a kidney from a parent or a 
child or from a haploidentical sibling 
(half-lives all approximately 16 years). 2 
Moreover, the outcome of transplanta-
tion of a kidney from a completely mis-
matched donor, whether known or 
anonymous to the recipient, is no di1 er-
ent from that of a haploidentical match. 3 
A better outcome is provided only by an 
HLA-identical sibling. ? ese data and 
the advances in laparoscopic nephrec-
tomy are the factors that probably 
account for the observations presented 
in the report by Horvat  et al. 1,4 
 THE NEED FOR A GLOBAL REGISTRY 
 ? e World Health Organization (WHO) 
is most receptive to e1 orts such as those 
of Horvat and coauthors. 1 It has a keen 
interest in developing a global knowl-
edge base in transplantation that can 
eventually provide rates of live and 
deceased organ donation. ? e WHO 
is aware of additional information on 
transplantation practices not presented 
by Horvat  et al. For example, the esti-
mate of kidney transplantation in Egypt 
alone approximates at least 1000, virtu-
ally all of these transplants being from 
live kidney vendors. Approximately 70 
kidney transplantations are performed 
in Cyprus each year, at least 60 % of 
these transplants being from live do-
nors. Live-donor kidney transplanta-
tion has now been accomplished in de-
veloping countries such as Kenya and 
Guyana. 
 ? e objective of establishing a data 
registry clearly includes the evaluation 
of transplantation performance. ? us, 
there are two other important data cat-
egories that might have been addressed 
by Horvat and coauthors 1 in their pur-
suit of the collected information from 
each country: donor gender and donor 
deaths. ? e legal sanction to sell a kidney 
seems to influence the donor gender, 
with a predominance of male vendors, 
for example, in Iran; in contrast, female 
altruistic donors provide approximately 
75 % of the kidneys for transplantation in 
many other countries. Horvat  et al. 1 
emphasize that one goal of a data regis-
try should be  ‘ enhancing the safety and 
ethical framework of this practice. ’ How-
ever, more recent accounts (not brought 
to attention by Horvat  et al. ) reveal a 
grim outcome of vendor transplantation 
for the  ‘ donor. ’ 5 
 THE KIDNEY TRANSPLANT 
FROM A VENDOR 
 ? e report by Horvat  et al. 1 also seems 
to be selective in the Discussion sec-
tion regarding the vendor donor, citing 
the program in Iran and concluding 
that there are lessons to be learned from 
 ‘ nations with successful wait list man-
agement [that] may serve as a model. ’ 
However, the authors provide no direct 
information regarding the Iranian wait 
list. Further, the report by Horvat  et al. 1 
overlooks the experience in neighboring 
Pakistan and the exploitation that is the 
reality of organ markets. 5 
 Nations with  ‘ successful wait list man-
agement ’ should include the following 
kinds of data if the program is to serve as 
a model and the data registry is to be com-
prehensive: 
   (i) How many end-stage renal disease 
patients die (for example, in Iran) 
each year without gaining access to 
the list; 
 (ii) ? e impact of the vendor kidney 
model on living related kidney 
transplantation in that country; 
 (iii) ? e impact of the live-vendor 
program on deceased donation of 
hearts and livers and other extra-
renal organs not readily obtainable 
from a live donor. 
 Among those who wish to present a 
vendor model as the ideal solution, some 
also suggest that the program should be 
 ‘ regulated. ’ 6 A component of that regu-
lation is to recommend a  xed price for 
the vendor. In contrast, the opponents 
of such markets dispute the possibil-
ity of  xing the vendor payment. 7 For 
example, in Iran, additional payments 
are made by the recipient ’ s family to 
the vendor ’ s broker that are evidently 
customary. 8 
 THE DECLARATION OF ISTANBUL 
ON ORGAN TRAFFICKING 
AND TRANSPLANT TOURISM 
 In 2004, World Health Assembly Reso-
lution WHA57. 18 urged member states 
 ‘ to take measures to protect the poor-
est and vulnerable groups from trans-
plant tourism and the sale of tissues 
and organs, including attention to the 
wider problem of international tra.  ck-
ing in human tissues and organs. ’ 9 ? e 
WHO has estimated that organ traf-
 cking and transplant tourism account 
for approximately 10 % of organ trans-
plants performed annually around the 
world. 10 ? ese issues became the sub-
ject of a summit convened in Istanbul 
from 30 April to 1 May 2008 ( Figure 1 ) 
by the Transplantation Society and the 
International Society of Nephrology. 
? e result of these deliberations was 
the Declaration of Istanbul on Organ 
Tra.  cking and Transplant Tourism. 8 
? e consensus achieved at the Istanbul 
Summit was remarkable. ? e Istanbul 
participants emphasized that organ traf-
 cking and transplant tourism should 
be prohibited because they violate the 
principles of equity, justice, and respect 
for human dignity. ? e Declaration is 
also clear regarding the consequences 
of transplant commercialism:  ‘ Because 
transplant commercialism targets im-
poverished and otherwise vulnerable 
donors, it leads inexorably to inequity 
and injustice and should also be prohib-
ited. To be e1 ective, these prohibitions 
must include bans on all types of adver-
tising (electronic and print), soliciting, 
or brokering for the purpose of trans-
plant commercialism. ’ 
 TRANSPLANT TOURISM 
 ? e report by Horvat  et al. 1 suggests ap-
propriately that organ tourism inL uences 
many countries in di1 erent ways, but the 
report does not specify how this inL u-
ence occurs. ? e Istanbul Declaration 
notes the following regarding transplant 
tourism: Travel for transplantation is the 
movement of organs, donors, recipients, 
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or transplantation professionals across 
jurisdictional borders for transplantation 
purposes. Travel for transplantation be-
comes  ‘ transplant tourism ’ if it involves 
organ tra.  cking and / or transplant com-
mercialism or if the resources (organs, 
professionals, and transplant centers) 
devoted to providing transplants to pa-
tients from outside a country undermine 
the country ’ s ability to provide transplant 
services for its own population. 11 
 Not all recipient travel to a foreign coun-
try to undergo transplantation is unethical. 
Travel for transplantation may be accepta-
ble if the following conditions are ful lled: 
 For transplantation from a live donor: 
 (i) ? e recipient has a dual citizenship, 
in the country of residence and in 
the destination country, and wishes 
to undergo transplantation from a 
live donor who is a family member 
in the destination country; or 
 (ii) ? e donor and recipient are geneti-
cally or emotionally related and wish 
to undergo donation and trans-
plantation in a country not of their 
residence to gain access to better 
health services. 
 For transplantation from a deceased donor: 
 (i) O.  cial regulated bilateral or multi-
lateral organ sharing programs exist 
between or among jurisdictions 
(countries). 
 However, travel for transplantation should 
not result in the denial of organs to people 
of the destination country because rich 
people who pay for organs are preferen-
tially cared for, nor should it impede the 
development of deceased or non-cash-paid 
live donation in the client country. 
 THE PREFERENCE FOR THE LIVE DONOR 
 ? e data from Cecka cited above also re-
vealed that the outcome of a live- donor 
transplantation — even unrelated — ex-
ceeded the outcome achieved with a 
deceased donor (half-life of 16 versus 
10 years for the deceased-donor trans-
plant). 2 Some have used those data to 
support unethical national practices. 
? is report was  led on the Internet 
from the Philippines by Dr Enrique 
Ona: Of the 690 kidney transplants done 
in the Philippines in 2006, 158 (23 % ) of 
these were done for foreign recipients. 
In 2007, a total of 1046 were done; 536 
(51 % ) of these were done in the 13 pri-
vate hospitals that strongly objected to 
and ignored the 10 % limit mandated by 
Philippine Administrative Order.  ‘ Two 
important facts on living donors have 
become established. One, it is safe to 
be a living kidney donor — one lives a 
normal life in terms of life expectancy, 
sexual activity, with no or little danger of 
a higher incidence of hypertension and 
albuminuria. Two, recipients with live 
donors have a signi cantly longer sur-
vival rate, compared to the best matched 
deceased  donors. ? e above  evidence-
based medical facts have added to the 
tremendous demand of patients with 
ESRD to seek kidney transplantation as 
early as possible (pre-emptive), to look 
for a living donor beyond their family 
circle, and regardless of racial source. ’ 12 
 CARE OF THE LIVE DONOR IS NEEDED 
 Horvat  et al. 1 conclude by suggesting 
that  ‘ communication across nations 
will continue to put living donation 
into the global context, enhancing the 
safety and ethical framework of this 
practice in the decades to come. ’ ? is 
is a worthy objective but is hardly as-
sured by a registry unless there is a 
prospective commitment. ? e live do-
nor cannot become the target source of 
kidney transplantation unless proper 
follow-up is provided, with the same 
emphasis of care that is a1 orded the 
recipient. 13 
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 Figure 1  Ι  Photograph from the summit that resulted in the Declaration of Istanbul on Organ 
Trafficking and Transplant Tourism . 
